Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Michael, Cecchini"'
Autor:
Aurel Prosz, Pranshu Sahgal, Brandon M. Huffman, Zsofia Sztupinszki, Clare X. Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada Likasitwatanakul, Orsolya Rusz, Istvan Csabai, Michael Cecchini, Yasmine Baca, Andrew Elliott, Peter Enzinger, Harshabad Singh, Jessalyn Ubellaker, Jean-Bernard Lazaro, James M. Cleary, Zoltan Szallasi, Nilay S. Sethi
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Homologous recombination (HR) and nucleotide excision repair (NER) are the two most frequently disabled DNA repair pathways in cancer. HR-deficient breast, ovarian, pancreatic and prostate cancers respond well to platinum chemotherapy and PA
Externí odkaz:
https://doaj.org/article/b6b069037e684be89e6db272774fcef6
Autor:
Aurel Prosz, Pranshu Sahgal, Brandon M. Huffman, Zsofia Sztupinszki, Clare X. Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada Likasitwatanakul, Orsolya Rusz, Istvan Csabai, Michael Cecchini, Yasmine Baca, Andrew Elliott, Peter Enzinger, Harshabad Singh, Jessalyn Ubellaker, Jean-Bernard Lazaro, James M. Cleary, Zoltan Szallasi, Nilay S. Sethi
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/7b071e78f9934ab7a55cfa9bc5e11b2f
Autor:
Rong Li, Francois Ghiringhelli, Antoine Italiano, Antoni Ribas, Paolo Antonio Ascierto, Michael Cecchini, Joseph Paul Eder, Kurt A Schalper, Sara I Pai, Mace Rothenberg, Ellen Pure, Wolf Herve Fridman, Fatima Mechta-Grigoriou, Guy Travis Clifton, Glenn Begley, Marina Kochetkova, Paolo Provenzano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Checkpoint inhibitors represent an effective treatment approach for a variety of cancers through their inhibition of immune regulatory pathways within the tumor microenvironment (TME). Unfortunately only a minority of patients with cancer achieve cli
Externí odkaz:
https://doaj.org/article/3536fd9b7adb4dc68227628c4f9989e9
Autor:
Chen Li, Ana Ferro, Shivani K. Mhatre, Danny Lu, Marcus Lawrance, Xiao Li, Shi Li, Simon Allen, Jayesh Desai, Marwan Fakih, Michael Cecchini, Katrina S. Pedersen, Tae You Kim, Irmarie Reyes-Rivera, Neil H. Segal, Christelle Lenain
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-8 (2022)
Li et al. report outcomes from the atezolizumab/isatuximab arm of the phase Ib/II MORPHEUS-CRC trial in patients with metastatic colorectal cancer. In addition, the authors leverage historical control data from the phase III IMblaze370 study to provi
Externí odkaz:
https://doaj.org/article/a2d8a6d7f97440f4b6e89b19aac1153c
Autor:
Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol Narang, Joseph Herman, Salma K. Jabbour, Christopher L. Hallemeier, Kimberly Johung, Krishan R. Jethwa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 15-23 (2021)
Purpose: Margin-negative (R0) resection is the only potentially curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC). Pre-operative multi-agent chemotherapy alone (MAC) or MAC followed by pre-operative radiotherapy (MAC + RT)
Externí odkaz:
https://doaj.org/article/6cbac6a58777403cbed48d1acbe64aa0
Autor:
Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Publikováno v:
JMIR Cancer, Vol 8, Iss 2, p e33859 (2022)
BackgroundExpert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community. ObjectiveUsing an oncologist-only quest
Externí odkaz:
https://doaj.org/article/b5128dc2db1f4f718a05df5e4722645d
Autor:
Lee Schwartzberg, Michael S Broder, Sikander Ailawadhi, Himisha Beltran, L Johnetta Blakely, G Thomas Budd, Laurie Carr, Michael Cecchini, Patrick Cobb, Anuraag Kansal, Ashley Kim, Bradley J Monk, Deborah J Wong, Cynthia Campos, Irina Yermilov
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0279227 (2022)
Expert consensus on the potential benefits of early cancer detection does not exist for most cancer types. We convened 10 practicing oncologists using a RAND/UCLA modified Delphi panel to evaluate which of 20 solid tumors, representing >40 American J
Externí odkaz:
https://doaj.org/article/cbc0f97f28e34b00868df9a023453036
Autor:
Matthew Walters, Stephen Young, Michael Cecchini, Houston Gilbert, Akshata Udyavar, Daniel DiRenzo, Sean Cho, Lisa Seitz, Kristen Zhang, Amy Anderson, Kimberline Gerrick, Olivia Gardner, Cheng Quah, Juan Jaen, William Grossman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4bb49219c48a4df9a64820fd1d9aed2c
Autor:
Meriem, Mokhtech, Joseph A, Miccio, Kimberly, Johung, Michael, Cecchini, Stacey, Stein, Amol K, Narang, Joseph M, Herman, John, Kunstman, Michael G, Haddock, Christopher J, Anker, Salma, Jabbour, Christopher L, Hallemeier, Krishan R, Jethwa
Publikováno v:
American Journal of Clinical Oncology. 45:450-457
Chemotherapy followed by margin-negative resection (R0) is the treatment of choice for patients with localized pancreatic ductal adenocarcinoma (PDAC). Neoadjuvant multiagent chemotherapy (MAC) or MAC then radiotherapy (RT) may optimize surgical cand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca4d49c9fe3121676b706f37a17a0b21
https://doi.org/10.1097/coc.0000000000000947
https://doi.org/10.1097/coc.0000000000000947
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:QIM22-192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7efffb0f70b4a1ed49b7880e340ce597
https://doi.org/10.6004/jnccn.2021.7192
https://doi.org/10.6004/jnccn.2021.7192